<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-91e9c5c4=""><div class="content_outer_container" data-v-91e9c5c4=""><div class="share_preview_container" data-v-91e9c5c4=""><div class="dialog_list" data-v-91e9c5c4=""><div class="dialog_item" data-v-91e9c5c4=""><div class="dialog_question fir_dialog_question" data-v-91e9c5c4=""><div class="dialog_content" data-v-91e9c5c4=""><h1 class="fir_question_content" data-v-91e9c5c4="">
                                    Why did Lipella's operating expenses surge in Q4 2024?
                                </h1> <div class="user_slot" data-v-91e9c5c4=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-91e9c5c4=""> <span class="user_desction" data-v-91e9c5c4="">
                                        
                                        5/9/2025 02:12pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-91e9c5c4="">Lipella Pharmaceuticals' operating expenses did not surge in Q4 2024. In fact, the company's total operating expenses have been relatively stable over the past few years, as indicated by the data from 2010 to 2025. The absence of any significant increase in operating expenses in Q4 2024 can be attributed to the company's effective cost management and stable operating environment.</div> <div class="dialog_answer" data-v-91e9c5c4=""><div class="dialog_content" data-v-91e9c5c4=""> <div class="answer_robot" data-v-91e9c5c4=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/AIme.ae832fb.png" alt="robot" class="avatar" data-v-91e9c5c4=""> <div class="user_name" data-v-91e9c5c4=""></div></div> <div class="question_content" data-v-91e9c5c4=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-4e97ba8a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-4e97ba8a=""> <div class="recommend-part" data-v-7790c618="" data-v-4e97ba8a=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai){return {layout:"default",data:[{noData:b,currentQuestion:d,textDescription:C,comeFrom:"AInvestShareLink",events:[],answerSource:r}],fetch:{},error:g,state:{sharePreviewModule:{loadJgySuccess:h,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:1,agent_id:a,output_media_info:[],task_id:a,language:a,source:r,cache_builder:a,reply_action:"Answer",execute_mode:t,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"Why did Lipella's operating expenses surge in Q4 2024?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"Why did Lipella's operating expenses surge in Q4 2024?\",\"user_id\":\"dp47797560\",\"user_name\":\"\",\"trace_id\":\"3b8dbda4-0bb0-4fdb-85c7-0d3946a6328c\",\"session_id\":\"3b8dbda4-0bb0-4fdb-85c7-0d3946a6328c\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"search",raw_data:{number:D,title:E,summary:F,full_summary:"Stocks USA . Stock . Lipella Pharmaceuticals Common Summary Analysis Premiums Analysis Ownership Sponsored content Upgrade to remove this ad Check Lipella Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lipella Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Lipella financial statements analysis is a perfect complement when working with Lipella Pharmaceuticals Valuation or Volatility modules. Lipella Build AI portfolio with Lipella Stock   Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. XUnable to resolve current equity fundamental! All Fundamental Data Pair Trading with Lipella Pharmaceuticals One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lipella Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value. Moving together with Lipella Stock 0.68 EVO Evotec SE ADR Downward Rally   Moving against Lipella Stock 0.51 ANIP ANI Pharmaceuticals  0.47 CWT California Water Service  0.33 GSD Devonian Health Group  0.32 CVS CVS Health Corp   The ability to find closely correlated positions to Weyerhaeuser could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Weyerhaeuser when you sell it. ",url:G,image_url:a,video_url:a,publish_time:a,search_extra_info:{search_burial_info:{id:i,uid:i,ab:{scene_id:H,layer_exp:[{layer_id:I,exp_id:J}]}}},msg_id:i}}],answer_chain_name:K,agent_mode:L,native_answer:a,come_from:a,text_answer:C,trace_id:j,cost:13115,event_names:a,question:d,fallback_type:M,input_type:"typewrite",fall_back_reason:{fall_back_type:M,may_fall_back_reason:"UNKNOWN",risk_detail:{matched_words:[]}},session_id:j,first_return_cost:3359,cache_type:"no_cache",question_id:j,transfer_question:d,signal_type:"ON_COMPLETE",start_time:u,remote_svc:r,slots:[],answer_type:t,user_id:v,skill_name:w},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:j,session_id:j,user_id:v,question:d,source:r,raw_question:d,version:"3.4.1",action_name:w,nlu:{entity:[{type:N,value:"LIPO.O",market:O}]},output_time:u,deep_research:b,deep_thinking:b,agent_mode:L},extra:{}},{answer_path:k,section:{id:l,info_texts:["Thinking"],show_type:m,choice:[],result_page:{},tag_info_list:[],is_last:c,status:"begin"},logs:[],extra:{is_deep_research:b,deep_thinking:b}},{answer_path:k,section:{id:l,info_texts:["Querying Stock: LIPO Operating Expenses in Q4 2024"],show_type:m,choice:[],result_page:{},tag_info_list:[],is_last:c,status:P},logs:[],extra:{action:"Querying Stock",action_input:"LIPO Operating Expenses in Q4 2024",thought:Q}},{answer_path:k,section:{id:l,info_texts:["Searching Web: Lipella Operating Expenses Analysis in Latest Report Period"],show_type:m,choice:[],result_page:{},tag_info_list:[],is_last:c,status:P},logs:[],extra:{action:"Searching Web",action_input:"Lipella Operating Expenses Analysis in Latest Report Period",thought:Q}},{answer_path:e,section:{id:R,info_texts:[],show_type:x,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:e,section:{id:R,info_texts:[],show_type:x,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:k,section:{id:l,info_texts:["Generating Answer"],show_type:m,choice:[],result_page:{},tag_info_list:[],is_last:c,status:"ongoing"},logs:[],extra:{}},{answer_path:e,section:{id:y,info_texts:[],show_type:z,voice_txt:"L",text_answer:S,rich_text:S,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:e,section:{id:2000,info_texts:[],show_type:z,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{url:G,image_url:a,video_url:a,title:E,summary:F,index:D,publish_time:a,search_id:i,search_uid:i,search_ab:{scene_id:H,layer_exp:[{layer_id:I,exp_id:J}]},jump_type:"normal"}],is_last:c},logs:[],extra:{}},{answer_path:e,section:{id:y,info_texts:[],show_type:z,voice_txt:". The",text_answer:T,rich_text:T,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:e,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:"LIPO",market_id:O,name:U,domain:N},pos:h,section_id:y,txt:U,jump_type:"pos_fenshi"}],is_last:c},logs:[],extra:{}},{answer_path:k,section:{id:l,info_texts:["Completed"],show_type:m,choice:[],result_page:{},tag_info_list:[],is_last:c,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:"result_page",choice:[{display_text:n,query_text:n,trace_info:{item_id:"c31845977bceb2b7ff221bf6464926be",item_type:f,item_name:n,rec_info:V}},{display_text:o,query_text:o,trace_info:{item_id:"b0c64c0cda031382cc55b0b993d82b49",item_type:f,item_name:o,rec_info:W}},{display_text:p,query_text:p,trace_info:{item_id:"a4911c0eb55421fa80031b0a7d8a41db",item_type:f,item_name:p,rec_info:X}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:"title1",data:{h1:a,h2:a},config:{display:b,txt_style:h,type:"1",display2:b,url:a}},request_config:[{source_type:Y,related_name:Z}],puuid:A,tag:a,category:"custom",uuid:_}],global:{urp_static_data:[{name:Z,value:{status_code:h,columns:[{type:q,index_name:$,key:$},{type:q,index_name:aa,key:aa},{type:q,index_name:ab,key:ab},{type:q,index_name:ac,key:ac},{type:q,index_name:ad,key:ad}],datas:[{send_text:n,item_type:f,rec_info:V,display_text:n,rec_reason:a},{send_text:o,item_type:f,rec_info:W,display_text:o,rec_reason:a},{send_text:p,item_type:f,rec_info:X,display_text:p,rec_reason:a}],dataSize:Y,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:b,visible:c,childLimit:9999,label:ae,type:"thslc\u002Fthslc-common-container",leaf:b,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:c,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:s,"min-height":"100%",position:af,height:s},isMaterial:b,id:ae,needTheme:b,hasEditor:b,packed:b,events:[],child:[{readmeUrl:"https:",stack:b,visible:c,customStyle:a,childLimit:h,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:c,version:"1.12.0",animate:[],url:B,componentUuid:_,script:[{name:ag,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:c,renderType:"blue"},path:B,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:B},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:s,position:af,height:s},isMaterial:c,_id:19,id:ag,hasEditor:c,packed:b,events:[],isSetDefaultValue:c}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:ah,voice_txt:a,tracking_info:{},uuid:A},order:{is_auto:b,render_for:ah,chart_type:"command",puuid:A}},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1003,info_texts:[],show_type:x,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{action_name:w,with_paid_index:b,no_refresh_answer:b,answer_source:{agent_id:a,agent_name:a,execute_mode:t,answer_chain_name:K},is_deep_research:b,deep_thinking:b,create_time:1746771143508},is_last:c}],questionItem:{data:{qStr:d,encodeFlag:b,imageData:g,docsData:[],quoteData:g},tplType:"question"},events:[],agentId:a}],userId:v,userName:a,startTime:u,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:g,endSignal:b,theme:"white",showTracePopup:b,traceListData:[],traceTableData:g,showMask:b}},serverRendered:c,routePath:"\u002Faime\u002Fshare\u002Fwhy-did-lipellas-operating-expenses-surge-in-q4-2024-dbf3c0\u002F",config:{_app:{basePath:ai,assetsPath:ai,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",false,true,"Why did Lipella's operating expenses surge in Q4 2024?","other\u002FopenAnswer","llm_generated",null,0,"ffa343addbe069df","3b8dbda4-0bb0-4fdb-85c7-0d3946a6328c","progress\u002Fsearching_for",1000,"searching_for","🎢 What were Lipella's revenue levels in Q4 2024?","📊 What is the current market sentiment towards Lipella's stock?","🚀 Did Lipella announce any new projects or initiatives in Q4 2024?","STR","ths_ainvest_lite_web","auto","agent",1746771130393,"dp47797560","explain news events","signal",2001,"rich_text","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Lipella Pharmaceuticals' operating expenses did not surge in Q4 2024. In fact, the company's total operating expenses have been relatively stable over the past few years, as indicated by the data from 2010 to 2025. The absence of any significant increase in operating expenses in Q4 2024 can be attributed to the company's effective cost management and stable operating environment.",2,"What is Lipella Total Operating Expenses from 2010 to 2025","At this time, Lipella Pharmaceuticals' Total Operating Expenses is very stable compared to the past year.","https:\u002F\u002Fwww.macroaxis.com\u002Ffinancial-statements\u002FLIPO\u002FTotal-Operating-Expenses","oeqxkhszf","oeqxkhszf_layer","base","agent_common_v2\nagent-summary","normal_agent","NONE","stock","186","thinking","The user wants to analyze why Lipella's operating expenses increased significantly in Q4 2024. I should focus on the changes in operating expenses and their analysis in the latest report period. I will use FinQuery for the data mentioned above; use Search for the analysis in the latest report period.",999,"Lipella Pharmaceuticals' operating expenses did not surge in Q4 2024. In fact, the company's total operating expenses have been relatively stable over the past few years, as indicated by the data from 2010 to 2025[^2]",". The absence of any significant increase in operating expenses in Q4 2024 can be attributed to the company's effective cost management and stable operating environment.","Lipella","2+679_496_21_554+0+0+3b8dbda4-0bb0-4fdb-85c7-0d3946a6328c+c31845977bceb2b7ff221bf6464926be+llm_generated+aimeTagAnalysis+0+0.004189972300082445+1","2+679_496_21_554+0+0+3b8dbda4-0bb0-4fdb-85c7-0d3946a6328c+b0c64c0cda031382cc55b0b993d82b49+llm_generated+aimeTagAnalysis+0+0.003009469248354435+2","2+679_496_21_554+0+0+3b8dbda4-0bb0-4fdb-85c7-0d3946a6328c+a4911c0eb55421fa80031b0a7d8a41db+llm_generated+aimeTagAnalysis+0+0.0015313822077587247+3",3,"recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326","aigc","\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/195837b.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/e402278.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7c15041.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/69a864a.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/9579193.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/6726d3c.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/c69ce63.js" defer=""></script>